Insider Trading History of Rosenblum Mark J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Rosenblum Mark J since 2005. This trader's CIK number is 1329154. At the time of last reporting, Rosenblum Mark J was the Exec VP Finance, CFO of Salarius Pharmaceuticals, Inc.. (stock ticker symbol SLRX). Also see all insider trading activities at Salarius Pharmaceuticals, Inc..

Note that in the past Rosenblum Mark J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Hemobiotech Inc (HMBT) by Rosenblum Mark J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2005 HMBT 2,000 $3,000 0 $0 0 $0

Yearly summary of insider trading at Salarius Pharmaceuticals, Inc. (SLRX) by Rosenblum Mark J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 SLRX 104,246 $34,852 0 $0 0 $0
2020 SLRX 12,000 $11,195 0 $0 0 $0

Yearly summary of insider trading at Advaxis, Inc. (ADXS) by Rosenblum Mark J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 ADXS 12,000 $48,000 0 $0 0 $0


Insider trading activities at 3 companies by Rosenblum Mark J:

1. Hemobiotech Inc (HMBT)

2. Salarius Pharmaceuticals, Inc. (SLRX)

3. Advaxis, Inc. (ADXS)

Table 1. Insider trading of Hemobiotech Inc (HMBT) by Rosenblum Mark J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2005-11-21 HMBT Buy 2,000 1.50 3,000

Table 2. Insider trading of Salarius Pharmaceuticals, Inc. (SLRX) by Rosenblum Mark J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-05-31 SLRX Buy 28,000 .18 5,040
2022-03-03 SLRX Buy 76,246 .39 29,812
2020-08-17 SLRX Buy 5,000 1.00 5,000
2020-02-19 SLRX Buy 2,000 .95 1,900
2020-02-13 SLRX Buy 5,000 .86 4,295

Table 3. Insider trading of Advaxis, Inc. (ADXS) by Rosenblum Mark J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-10-24 ADXS Buy 12,000 4.00 48,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rosenblum Mark J (Exec VP Finance, CFO of Salarius Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.